高血压的药理-表观遗传学:专注于微RNA
Serge Yaacoub1, Ammar Boudaka2, Ali AlKhatib3
1Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Molecular and cellular biochemistry
|February 29, 2024
概括
微RNAs (miRNAs) 在高血压的发展和治疗中起着至关重要的作用. 本综述探讨了这些分子如何通过表观遗传机制影响常见高血压药物的有效性.
科学领域:
- 心血管科学 心血管科学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血压是心血管疾病和死亡的主要原因,到2025年将影响15亿人.
- 它的病理生理学是复杂的,涉及诸如氧化失调和活性氧物种等因素.
- 新出现的证据强调了表观遗传学,包括微RNA (miRNA) 在高血压中的作用.
研究的目的:
- 审查微RNAs (miRNAs) 和高血压药物治疗之间的实验确定关联.
- 突出表观遗传机制是对抗高血压药物反应的基础.
- 阐明miRNA在高血压的药理表观遗传学中的作用.
主要方法:
- 对现有文献进行批判性审查.
- 对miRNA和高血压的实验研究的分析.
- 专注于表观遗传机制和药物反应.
主要成果:
- 微RNA与高血压的病理生理学有关.
- 表观遗传修饰,包括涉及miRNAs的基因修饰,会影响药物的疗效.
- 坎德沙坦,克洛皮多格雷尔,阿司匹林和他类药物等特定药物与这些通路相互作用.
结论:
- 微RNA是高血压药物治疗和药物-表观遗传学的关键参与者.
- 了解miRNA介导的表观遗传调节对于优化高血压治疗至关重要.
- 对miRNA药物相互作用的进一步研究可以导致更有效的治疗策略.
相关概念视频
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Human Genetics
566
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
566
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
636
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
636
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61


